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INTRODUCTORY PARAGRAPH  33 
 34 
Bacterial septicaemia is a major cause of mortality, but its pathogenesis remains poorly 35 
understood. In experimental pneumococcal murine intravenous infection, an initial reduction 36 
of bacteria in the blood is followed hours later by a fatal septicaemia. These events 37 
represent a population-bottleneck driven by efficient clearance of pneumococci by splenic 38 
macrophages and neutrophils, but as we show here,  accompanied by occasional 39 
intracellular replication of bacteria that are taken up by a sub-set of CD169-positive splenic 40 
macrophages. In this model, proliferation of these sequestered bacteria provides a reservoir 41 
for dissemination of pneumococci into the bloodstream, as demonstrated by its prevention 42 
using an anti-CD169 mAb treatment. Intracellular replication of pneumococci within CD169+ 43 
splenic macrophages was also observed in an ex vivo porcine spleen, where the 44 
microanatomy is comparable to humans. We also showed that macrolides, that effectively 45 
penetrate macrophages, prevented septicaemia whereas beta-lactams, with inefficient 46 
intracellular penetration, failed to prevent dissemination to the blood. Our findings define a 47 
shift in our understanding of the pneumococcus from an exclusively extracellular pathogen to 48 
one with an intracellular phase. These findings open the door to the development of 49 
treatments that target this early, previously unrecognized intracellular phase of bacterial 50 
sepsis. 51 
 52 
  53 
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INTRODUCTION 54 
 55 
Despite the existence of highly evolved mechanisms of immunity, humans may still develop life-56 
threatening sepsis1. Clinical management of sepsis is challenging and the discouraging outcome 57 
of many anti-sepsis trials plus increasing incidence of antimicrobial resistance are among the 58 
compelling reasons  for further research to better understand the pathogenesis of invasive 59 
infection (septicaemia) and sepsis2. The bacterium Streptococcus pneumoniae (pneumococcus) 60 
is one of the major causes of serious disease and death3. About half of patients with 61 
pneumococcal pneumonia are septicaemic and the presence of bacteria in the blood correlates to 62 
disease severity and outcome4 but it is not known why only a proportion of patients are 63 
septicaemic  when there are no obvious co-morbidities or risk factors5. Notwithstanding decades 64 
of clinical and experimental research, there remain major gaps in our understanding of the early 65 
events in invasive pneumococcal infection6. Major unanswered questions are  how pneumococci 66 
sustain a septicaemia that develops into clinical sepsis. Following intravenous inoculation of 67 
pneumococci in animals there is a consistent infection pattern in which a rapid reduction in the 68 
numbers of bacteria occurs such that within hours few, if any, organisms are detectable in the 69 
blood, a stage known as the ‘eclipse phase’7,8. In animals lacking adaptive immunity to the 70 
pneumococcus, this eclipse phase results from innate immune clearance of bacteria by splenic 71 
macrophages but, depending on the virulence of the pneumococcal strain, it may later be 72 
followed by the emergence of septicaemia and lethal sepsis9. Recently, time-lapse microscopy 73 
observations have added important data on the dynamic role of neutrophils in the containment of 74 
pneumococcal infection a few hours after infection10. However, the host and microbial 75 
determinants of the transition from the contained infection during the eclipse phase to overt 76 
septicaemia and sepsis remain poorly understood.    77 
 78 
Previously we showed that the eclipse involves a single-cell population bottleneck8,11, which is 79 
succeeded by a ‘recovery phase’ with detection in the blood of pneumococci derived in most 80 
cases from clonal expansion of one founder bacterium. These events raised the critical question 81 
of how, within a few hours of virtual elimination of bacteria from the blood, a single founding 82 
pneumococcus could result in septicaemia. We hypothesised an extravascular site of 83 
pneumococcal replication, most likely in the spleen, because it is the major site of pneumococcal 84 
clearance12-14. Accordingly, we investigated the temporal pattern of localisation of bacteria in the 85 
spleen following intravenous inoculation. In particular, we investigated the involvement of different 86 
splenic macrophages. Here we show that the splenic metallophilic macrophages that are both 87 
CD169+ (Siglec-1, Sialoadhesin) and sulphated glycan positive (mannose receptor binding 88 
glycans; MRG+)15,16, henceforth referred to as CD169+act as a “sanctuary” during the first hours 89 
of pneumococcal infection. Our data reveal that septicaemia is initiated following uptake of 90 
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pneumococci by CD169+ macrophages in mice and pigs. Within the CD169+ macrophages the 91 
internalised bacteria evade clearance, undergo replication, then cause macrophage lysis and 92 
disseminate to the blood. Further, we show that antimicrobial therapy, specifically targeted to 93 
abort this phase of intracellular replication, can prevent the occurrence of pneumococcal 94 
septicaemia.   95 
 96 
 97 
 98 
RESULTS   99 
 100 
Live pneumococci are present in the spleen prior to septicaemia.  101 
To investigate the events leading to the eclipse phase and the subsequent occurrence of 102 
septicaemia, we hypothesised that there was an extravascular reservoir of pneumococci in the 103 
spleen. We induced pneumococcal infection in mice by intravenous inoculation of 1X106 104 
pneumococci. Consistent with previous results8, bacteria were still present in the blood at 6 hours 105 
(h) after challenge, but were effectively cleared at 8h (eclipse phase). Following the virtual 106 
elimination of bacteria from the blood, bacteria re-appeared following the eclipse phase and by 107 
24h mice showed signs of systemic infection (Fig. 1a). Using confocal microscopy, bacteria were 108 
visualised within the spleen during the eclipse phase (6 and 8h).  Several staining combinations 109 
on tissue sections have been used to see the different splenic compartments (Supplementary 110 
Figure 1 a-b-c), showing the bacteria localised mainly in the marginal zone, the area surrounding 111 
the white pulp (Fig. 1c-d; Supplementary Figure 1 f-g). Higher magnification, revealed that 112 
bacteria were present as discrete clusters within the splenic tissue (Fig. 1e). In contrast, we did 113 
not detect bacteria in cultures of lung, cervical lymph node, liver and kidney homogenates at 8h.  114 
  115 
Foci of infection are founded by a single bacterium 116 
To further characterise the details of the persistence of pneumococci in the spleen, mice were 117 
sacrificed at 5 minutes (min), 30 min, 4 h, 6h and at 8h post-challenge with 1 X 106 pneumococci. 118 
Five and thirty min post-challenge, microscopy of spleen sections demonstrated only single 119 
bacterial cells or diplococci, localised mainly to the marginal zone macrophages in the marginal 120 
sinus (Fig. 2a; Supplementary figure 1 d). In contrast, at 4, 6 and 8h after challenge, 121 
pneumococci were predominantly in the marginal zone metallophilic macrophages (Fig. 1c-d; Fig. 122 
2 b-d, Supplementary figure 1 e-g). The number of pneumococci in the clusters within the 123 
metallophilic macrophages increased over time (Fig. 2b-e).  At 8h bacterial clusters appeared to 124 
extend to several adjacent host cells (Fig. 2d) and there were some single bacteria foci (Fig. 2e). 125 
These observations suggested lysis of infected cells, and release of bacteria to establish newly 126 
infected host cells.  127 
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To determine if the clusters of pneumococci originated as the result of the replication of single 128 
pneumococci, or through sequential phagocytic events by host cells, mice were inoculated 129 
intravenously with a 1:1 mixture of D39 strains expressing green fluorescent protein (GFP) or red 130 
fluorescent protein (RFP)17. The results showed that bacterial foci at 6h post-challenge consisted 131 
entirely of either green or red fluorescent bacteria (Fig. 2f). Multiple spleen samples showed 132 
complete absence of dual-labelled foci (2 spleens, 30 fields, Supplementary Table 2), clearly 133 
demonstrating that each infection focus was initiated by a single founder bacterium. Based on 134 
this finding and the bacterial counts within a focus (Fig. 2a-e), we estimated a mean generation 135 
time of approximately 60 min for pneumococcal replication within splenic tissue macrophages (5 136 
generations of 60 min from 1 cell after 1h of infection to 32 cells at 8h). Comparable foci of 137 
infection were detected when mice were infected with a serotype 4 strain TIGR4 or a non-138 
capsulated derivative of D39 (Supplementary Figure 2). 139 
Previous work demonstrated the detrimental effect of neutrophil (PMN) depletion on bacterial 140 
clearance during the eclipse phase8. Therefore, we investigated the presence of neutrophils in 141 
spleen sections at 0, 6 and 8h post-challenge. Consistent with the recent observation showing 142 
involvement of mobile PMNs in early splenic clearance of pneumococci10, we detected PMNs at 143 
all times almost exclusively in the red pulp (Fig. 2 g) with an increase in number over time (Fig. 2 144 
k). This increase was not uniform; PMNs localised next to pneumococcal cells and the number of 145 
PMNs per bacterial cluster also increased when comparing the samples at 6 and 8h (Fig. 2l). 146 
Clusters of pneumococci in red pulp macrophages were surrounded by PMNs (Fig. 2h), but 147 
neutrophils were not seen during the first 8 h in the proximity of the infectious foci in the marginal 148 
zone macrophages (Fig. 2i) or metallophilic macrophages (Fig. 2j).  149 
 150 
CD169+ macrophages preferentially accumulate pneumococci  151 
Soon after challenge, most bacteria were found next to the marginal sinus, the region where 152 
macrophages sample foreign antigens18. To investigate the fate of bacteria within the spleen, the 153 
distribution and number of infectious foci was determined 6h after intravenous challenge with 106 154 
CFU/animal (Fig. 3 a). The compartments considered for this analysis were the white pulp, 155 
containing B and T cells (B220+ and KT3+ respectively), the marginal metallophilic macrophage 156 
area (CD169+ and MRG+)15,16, the marginal zone macrophage area (SIGN-R1+) and the red pulp 157 
(F4/80+) (Supplementary Figure 3 a-c). At this dose, the majority of infectious foci were in the red 158 
pulp (Supplementary Figure 3). After infection with a lower dose (105 CFU/animal) the clusters of 159 
pneumococci were predominantly observed next to the marginal sinus, the location of the 160 
marginal zone macrophages and the metallophilic macrophages, on the outside and inside of the 161 
sinus respectively (Supplementary Figure 3). Since the size of each compartment differs, multiple 162 
images of whole spleen sections were acquired and analysed to normalise the counts in the 163 
different areas of the spleen (Supplementary Figure 4). After normalisation, the data clearly 164 
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showed that the proportion of infected CD169+ metallophilic macrophages, was significantly 165 
higher both at the high and at the low dose compared to any other compartment (Fig. 3a). 166 
Counting the number of bacteria present in the macrophage-associated clusters at 6h,  showed 167 
marginal zone macrophages (MZM) harbouring mainly single bacteria, metallophilic 168 
macrophages (CD169+) with foci of about 4 bacteria and red pulp macrophages (F4/80+) with 169 
about 8 bacteria/focus (Fig. 3b).  170 
 The surface marker CD169, defining the metallophilic macrophages, previously was shown to be 171 
involved in the phagocytosis of sialylated bacteria19-21. While pneumococci are not sialylated, they 172 
possess sialidases, including NanA, that contains a sialic acid binding domain previously shown 173 
to be involved in adhesion and invasion of host cells22. To test if the surface protein NanA could 174 
be involved in macrophage uptake, we repeated the infection experiment with a nanA deletion 175 
mutant, that has reduced virulence (Fig. 3c), and two recombinant strains expressing either only 176 
the N-terminal lectin binding domain (NanAΔ290-786) or the C-terminal sialidase domain 177 
(NanAΔ76-282). Both the nanA deletion mutant and the lectin domain mutant, known to be 178 
involved in sialic-acid-mediated host cell binding and invasion22, showed reduction of the number 179 
of foci in the metallophilic macrophages (Fig. 3d). It should be noted that the nanA-recombinants 180 
are constructed on the background of the nanA deletion mutant and that the recombinant 181 
expressing the lectin-like domain (NanAΔ290-786) regains the capacity to localise to CD169+ 182 
cells.  183 
 184 
CD169 macrophages are the source of bacteria causing invasive disease 185 
Guided by reports showing that anti-CD169 antibodies prevented uptake of porcine reproductive 186 
and respiratory virus (PRRSV) by CD169+ macrophages23, we treated mice intravenously with an 187 
anti-CD169 mAb (Rat IgG2a,k, Clone: 3D6.112) 30 minutes prior to i.v. challenge with bacteria. 188 
At 4h post-infection, treatment with anti-CD169 prevented formation of foci in the metallophilic 189 
macrophages (Fig 3f). At 24h post-infection, the treatment with anti-CD169 prevented 190 
bacteraemia in almost all mice (Fig.3g) and this correlated with increased survival at 72h (Fig 3h). 191 
At 72h post-infection (or at the disease severity endpoint) almost all the mice treated with the 192 
CD169 mAb did not have detectable bacteria in blood and spleen (Supplementary Figure 5 a). It 193 
should be noted that the CD169 mAb, used as a single dose prior to challenge, was still 194 
detectable on the metallophilic macrophage surface at the conclusion of the experiment 195 
(Supplementary Figure 5 d).  196 
Having established the importance of CD169+ macrophages in the pathogenesis of 197 
pneumococcal sepsis in our i.v. murine challenge model, we next sought to investigate the 198 
specific role of the CD169 surface expression marker in the interaction between bacteria and 199 
metallophilic macrophages. We compared infections of CD169 knock out mice and isogenic 200 
C57/BL6 controls 16. We found no difference in the bacterial counts in blood or spleen, nor in the 201 
7 
 
size of infectious foci in the spleen  (Supplementary Figure 5 f-g-h-i). These findings provided no 202 
evidence to support a direct role of CD169 itself in mediating interactions between pneumococci 203 
and metallophylic macrophages. However, C57/BL6 mice differ from CD1 mice in that splenic 204 
clearance is less efficient, blood counts are 100 fold higher and there is no eclipse phase (Fig 1a-205 
b and Supplementary Figure 5 f-g), which limits the validity of the data by not allowing to evaluate 206 
the role of metallophylic macrophages in pneumococcal sepsis founded by a single cell 207 
bottleneck.   208 
 209 
Intracellular localisation of pneumococci 210 
To investigate whether bacteria in a splenic focus were extracellular or intracellular we used a 211 
number of different approaches. To delineate host cell plasma membrane, splenic sections 212 
infected with GFP-expressing bacteria were labelled with WGA (wheat germ agglutinin). The 213 
infection foci at 4h post-infection were enclosed in single host cells. The use of GFP-expressing 214 
bacteria allowed differentiation of intact pneumococcal cells from lysed bacteria, as shown in the 215 
orthogonal view of a representative multi-stack image acquired using confocal microscopy (Fig. 216 
4a-c). This image showed a cluster of pneumococci clearly identifiable between the cell nucleus 217 
(DAPI+) and the plasma membrane (WGA+). Its localisation was confirmed after deconvolution 218 
and 3D reconstruction of the tissue (Fig. 4d-e). Additionally, transmission electron microscopy 219 
showed groups of bacteria that localised within the host cell cytoplasm, without evident 220 
delimitation by a vacuolar membrane (Fig. 4f-g). The fine characterisation of the subcellular 221 
localisation of the bacteria within cells was impossible with these whole organ sections and must 222 
await the establishment of a validated model of primary cell culture of splenic CD169+ tissue 223 
macrophages. 224 
To provide further evidence of the intracellular location of pneumococci, we employed the 225 
excellent penetration of macrolide antibiotics into macrophages (10-40 mg/L cell: 226 
extracellular concentration ratio, C/E ratio), compared to beta-lactams (C/E ratio <0.2 mg/L)24. We 227 
hypothesised that we would detect differences in prevention of septicaemia in mice treated using 228 
an ultra-short course of each drug. Erythromycin (1.5 mg/animal; half-life 48 min; Minimum 229 
Inhibitory Concentration (MIC) 0.06 mg/L) and ampicillin (0.5 mg/animal, half-life 50 min, MIC 230 
0.12 mg/L) were administered intraperitoneally at 1 and 5h post-infection. The doses were 231 
calculated so that the plasma concentration of both drugs would decrease below the MIC by 11h 232 
post-infection. Both antibiotics were effective in clearing pneumococci from the blood in the first 233 
24h (Fig. 4h), but only erythromycin prevented later outgrowth of bacteria resulting in complete 234 
resolution of the infection and survival of mice (Fig. 4i-j). The ampicillin-treated animals showed a 235 
survival rate comparable to the control group treated with PBS (Fig. 4i). These data are in 236 
accordance with macrolides being effective in the sterilisation of an intracellular bacterial 237 
reservoir and thus prevention of late onset septicaemia.   238 
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 239 
A pig model confirming CD169+ replication-permissive splenic macrophages 240 
There are anatomical differences between human and mouse spleens. In particular, the human 241 
spleen has a relatively smaller white pulp, no marginal zone and importantly, the CD169+ 242 
macrophages localise to the perifollicular area, mostly associated to sheathed capillaries25,26. 243 
Human capillary sheaths are thus predicted to have a function similar to  the marginal zone in 244 
mice and rats26. For these reasons, the use of a second model was of crucial importance to 245 
determine the potential for translation of our results to humans26. The porcine spleen represents a 246 
suitable model as it closely resembles its human counterpart, with a comparable microanatomy 247 
and subpopulations of splenic macrophages27,28 where CD169 is expressed by the perifollicular 248 
sheath macrophages29,30. Importantly the porcine experimental pneumococcal infection model 249 
also shows an eclipse phase following challenge31. Based on previous experience with porcine 250 
organ perfusion models32, we set up a normothermic, ex vivo porcine spleen perfusion model to 251 
test the dynamics of pneumococcal infection. The model invloves immediate perfusion of abattoir-252 
sourced porcine spleens, followed by 5h perfusion with heparinised autologous blood. In this 253 
model it was possible to run a pneumococcal infection for 5h; long enough to study the critical 254 
early stages of infection. Thirty minutes after starting perfusion, the arterial circuit was injected 255 
with 6.5 x 107 CFU S. pneumoniae D39 (almost 105 CFU/ml). Subsequently, blood samples, 256 
spleen biopsies, and blood-gas parameters were taken at 30 min, 2, 4 and 5h. While 257 
pneumococci grew with a normal doubling time in heparinised pig blood (Fig 5a), the counts in 258 
the blood samples of the ex vivo model showed a steady decrease over time, while counts in the 259 
spleen steadily increased (Fig. 5b). This indicated that the spleen was performing its clearance 260 
role in this infection model. This porcine perfusion model of infection mirrored the data obtained in 261 
the mouse model. Bacterial clusters were found in increased numbers over time (Fig. 5c-e). In 262 
addition, independent foci derived from single bacterial cells were observed after infection with a 263 
mixed population of GFP- and RFP-expressing pneumococci (Fig. 5f-h). CD169+ macrophages in 264 
the porcine spleen localised in the peri-follicular zone (Fig. 5i-j). Analysis of spleen biopsies 265 
showed that, 5h post-infection, all foci of pneumococci were in CD169+ macrophages. The data 266 
from this whole organ pig model confirmed that early after infection single pneumococci are taken 267 
up by CD169+ macrophages and that these cells are permissive for rapid bacterial replication. 268 
 269 
 270 
  271 
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 272 
DISCUSSION  273 
 274 
A conspicuous deficiency in our understanding of the pathophysiology of sepsis has been in 275 
detailing the host-microbial interactions occurring before the triggering of the catastrophic host 276 
inflammatory responses that are characteristic of overwhelming sepsis. Even when initially 277 
infected with many thousands of bacteria, our previous research showed that pneumococcal 278 
septicaemia is initiated by a single bacterial cell8,33. Recent data have reported the dynamics of S. 279 
pneumoniae clearance dependent on red pulp and marginal zone macrophages, aided by mobile 280 
neutrophils10. However, neither our work on the single cell bottleneck8,33, nor the time-lapse 281 
imaging of pneumococcal clearance in the spleen10, provided knowledge of how the founding 282 
organisms survive the highly efficient host innate immunity mechanisms. Now, here we have 283 
shown that a small number of bacteria occur within CD169-positive macrophages within the 284 
spleen and that these host cells represents an immune-priviledged sanctuary and a reservoir for 285 
the reseeding of bacteria into the blood to cause septicaemia and sepsis. Importantly, these 286 
findings are not exclusively based on the murine model, but are confirmed by data in the pig; a 287 
model of high functional relevance and predictive value for humans27,28. There is an obvious  288 
difference between the mouse and pig i.v. challenge models, which are designed to study events 289 
in sepsis in the absence of pneumonia, and the most frequent human invasive disease which is 290 
sepsis associated with pneumonia. Thus, other studies are required, including human clinical or 291 
autopsy samples, to establish the relative importance of the spleen, and intracellular replication 292 
therein, in the development of sepsis in the presence and absence of overt pneumonia. In 293 
addition to giving a revised perspective on early events leading to septicaemia, our observations 294 
have immediate therapeutic implications because they show that septicaemia and sepsis can be 295 
prevented by early short term administration of antimicrobials that target the early intracellular 296 
bacterial population. In the demonstration of this conclusion, macrolides were much superior to 297 
beta-lactams, presently the first choice therapy for pneumococcal pneumonia5, in preventing 298 
septicaemia. This is perfectly in line with the call for intracellularly active drugs to fight multi-drug 299 
resistant staphylococcal infections, another extracellular pathogens found to hide in intracellular 300 
sanctuaries34.  301 
 302 
In a murine model of pneumococcal sepsis, we have documented the importance of replication 303 
within splenic CD169+ metallophilic macrophages, as an anti-CD169 antibody blocked bacterial 304 
uptake into these cells and protected against subsequent invasive disease. CD169 (Siglec-1 or 305 
Sialoadhesin) is a surface lectin receptor of macrophages reported to be involved in binding and 306 
uptake of a variety of sialylated viruses and bacteria19-21,35,36 but a role of CD169 in uptake of non-307 
sialylated bacteria, such as pneumococci, has not been previously reported. It does appear, 308 
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however, that sialic acid recognition by pneumococci is important because a mutant bacteria 309 
lacking the main pneumococcal sialidase, NanA, or the lectin domain of NanA showed reduced 310 
localisation to the metallophilic macrophages. Significantly, the lectin domain of NanA has 311 
previously shown to be required for sialic acid mediated invasion in other tissues 22, consistent 312 
with the suggestion that NanA mediates binding of pneumococci to macrophages, most likely to 313 
sialylated surface proteins. We conclude that while CD169 positive cells are critical, CD169 itself 314 
might not be directly involved. 315 
To further examine the role of CD169 we infected CD169 KO mice, which still show the same 316 
ringlike distribution of MGR+ metallophilic macrophages around the white pulp (Fig. 5Si). As we 317 
saw that pneumococci localised to the marginal metallophilic macrophages with equal abundance 318 
in the knock out mice and the wt controls, this implies that CD169 is not directly involved in 319 
pneumococcal uptake into these macrophages and that the anti-CD169 antibodies are preventing 320 
infection of marginal metallophilic macrophages through indirect effects. For example, if CD169 321 
exists in a molecular complex with other molecule(s) required for pneumococcal uptake by 322 
macrophages, antibodies directed to CD169 could block their function through steric effects. It 323 
has also been demonstrated that under some circumstances antibodies to CD169 can trigger 324 
endocytosis and non-specifically affect phagocytosis of latex beads and bacteria37. Nevertheless, 325 
the message of the studies reported here is that pneumococcal interaction with CD169+ 326 
macrophages in the spleen can be a critical precursor of septicaemia and sepsis. Invasive 327 
pneumococcal disease defined as bacteraemia without known primary focus or  humans .   328 
 329 
The functions of CD169+ macrophages are poorly defined but there are no reports that they 330 
represent a classical anti-microbial cell populations. Indeed pneumococcal survival and growth 331 
has not been reported in “typical” macrophages8,38-41, including splenic red pulp macrophages10. 332 
To date,  CD169+ metallophilic macrophages have been implicated mainly in induction of 333 
adaptive immunity by enhancing antigen availability for CD8 T cell and B cell activation, as shown 334 
by their permissiveness for viral replication in mice and pigs42,43. Adaptations enabling productive 335 
viral infection in CD169+ cells include upregulation of Usp18, which inhibits signalling through the 336 
IFN-α and IFN-β receptors. CD169+ macrophages also have been shown to express higher 337 
levels of suppressors of cytokine signalling, which suggests unresponsiveness of these cells to 338 
selected stimuli42,43. CD169+ macrophages migrate to B cell follicles after LPS stimulation and 339 
this correlates with enhanced antibody responses to antigens targeted to these cells indicating 340 
that these macrophages can sense inflammatory stimuli44,45. Our data now show that they have a 341 
broader permissive state to infection than previously understood and that this permissive state 342 
includes intracellular bacterial replication. Combining this finding with the lack of neutrophil 343 
recruitment to the vicinity of infected CD169+ macrophages suggests that CD169+ macrophages 344 
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are an Achilles heel of innate immunity to pneumococcal infections and this extracellular 345 
pathogen exploits their relatively ineffective bactericidal mechanisms. 346 
 347 
For some bacterial pathogens an intracellular phase is well-known, for example Salmonella 348 
spp.46, and events leading to its invasive infection have been defined. However comparable data, 349 
especially insight from translational models, is not available for many pathogens, including the 350 
pneumococcus, whose within-host life style has been considered as extracellular. The 351 
intracellular phase described here documents a significant departure from accepted dogma. It 352 
alters perceptions of how pneumococcal bacteraemia occurs, despite efficient clearance 353 
mechanisms provided in the spleen, jointly by macrophages, complement and neutrophils10. It is 354 
remarkable that, despite life-threatening  septicaemia being a relatively commonplace 355 
occurrence, so many gaps in our knowledge exist, including the tissue origins of bacteria and 356 
how they enter the vascular compartment and what leads to their replication to cause 357 
septicaemia47. Nevertheless a major lesson from the historical literature is that the sustained 358 
presence of bacteria in the blood cannot be plausibly explained by the one-off entry into the 359 
blood, but likely requires an extravascular immune-priviledged focus48,49, which once identified 360 
can alter strategies for intervention34. In the present studies, we identify such a crucial 361 
extravascular, intracellular site of replication in splenic macrophages that initiates dissemination 362 
of pneumococci. Importantly, the intracellular replication phase providing a jump start for single 363 
bacterial cells, also explains the generation of a monoclonal bacteraemia founded by a single-cell 364 
bottleneck that is observed at low multiplicities of infection8. 365 
 366 
In summary, our findings define a crucial intracellular phase in the pathogenesis of invasive 367 
disease caused by the pneumococcus, classically considered to be the quintessential example of 368 
an extracellular bacterial pathogen. While the relevance of our findings for subacute bacteraemia 369 
or bacteraemia without a known primary focus appears evident, the applicability of our findings 370 
for pneumonia-associated bacteraemia will have to be defined. The findings open the door to the 371 
investigation of treatments that target this early, previously unrecognised yet critical intracellular 372 
phase of bacterial sepsis. Judicious use of anti-host therapeutic strategies or antimicrobials 373 
capable of efficient penetration of host cells may abort this crucial phase that is essential for 374 
initiating bacterial dissemination50. At the early intracellular stage in the pathogenesis, the 375 
numbers of organisms that need to be destroyed are relatively small, because this coincides with 376 
an extreme population bottleneck. Eliminating small numbers of intracellular bacteria is less 377 
challenging than contending with a much larger biomass, or even biofilm, consisting of millions of 378 
extracellular bacteria typical of the later stages of sepsis.  379 
 380 
  381 
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Methods 382 
 383 
Pneumococcal strains and growth conditions 384 
S. pneumoniae strain D39 (serotype 2), its non-encapsulated derivative R651,52, a 385 
sialidase/neuraminidase nanA (SPD_RS07935) deletion mutant53, the serotype 4 strain TIGR454, 386 
and GFP and RFP fluorescent D39 (kindly provided by Jan Willem Veening, Groningen)17, were 387 
used in this study. A capsule deletion mutant of D39 expressing GFP was constructed by 388 
replacing the capsule locus with a kanamycin cassette55. All pneumococcal strains were cultured 389 
in Tryptic Soy Broth (TSB, Becton Dickinson) which in the case of green fluorescent (GFP) and 390 
red fluorescent (RFP) D39 was supplemented with 5 mg/L chloramphenicol (Sigma-Aldrich).  391 
Strains were also grown on blood agar plates consisting of Tryptic Soy Agar (Becton Dickinson) 392 
supplemented with 3% v/v defibrinated horse blood. All strains were cultured at 37oC, 5% v/v 393 
CO2. For transformations, competence was induced by addition of competence stimulating 394 
peptide 1 (CSP-1) to a final concentration of 0.625 μg/mL. 395 
  396 
Construction of nanA deletion mutants 397 
Three nanA mutants were constructed in D39. One strain was constructed lacking the region 398 
encoding the sialidase domain (NanAΔ290-786), one lacking the lectin-like domain (NanAΔ290-399 
786), and an inactivating insertion mutant. Unmarked mutants were constructed by transforming 400 
with PCR generated recombinant constructs (Supplementary Table 2) using a two step approach 401 
(Sung et al. 2001). Mutants showed absence of any SNP in the cloned portion by Sanger 402 
sequencing.  403 
 404 
Ethics statement 405 
All studies in Leicester utilising CD1 mice were performed in accordance with United Kingdom 406 
Home Office licence PPL60/4327 and P7B01C07A, and were approved by the University of 407 
Leicester Ethics Committee. All mice were scored for signs of disease56. Animals were culled at 408 
pre-determined time points, or at the point at which they showed moderate signs of disease in 409 
accordance with the Home Office Licence. 410 
The animal protocols used for the KO mice in this study were approved by the Ethical Review 411 
Committee of the University of Dundee. All procedures were conducted according to the 412 
requirements of the United Kingdom Home Office Animals Scientific Procedures Act, 1986, under 413 
PPL PB232D3BA. 414 
 415 
Mice 416 
Eight-week old, female, outbred CD1 mice from Charles River (Margate, Kent CT9 4LT UK) were 417 
used in this study. Before use, mice were kept for at least 1 week under standard conditions, in 418 
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the Central Research Facility animal facility at the University of Leicester, according to its 419 
guidelines for the maintenance of laboratory animals57-60. Blood samples from mice were 420 
collected by cardiac puncture under terminal anaesthesia, and treated with 100 U/ml of heparin 421 
(Sigma Aldrich, UK) to prevent blood coagulation. Mice were culled by cervical dislocation and 422 
death confirmed before the organs (spleen, lung, kidneys, cervical lymph nodes and liver) were 423 
collected post mortem. Mouse organs were either homogenised in 1 ml of TSB containing 10% 424 
v/v glycerol, for quantification of colony forming units (CFU), or fixed and embedded for 425 
sectioning.  426 
The generation of Sialoadhesin KO (CD169 KO) mice has previously been described 16.  All wild-427 
type (WT) and CD169 KO mice used in experiments were derived from heterozygotes back-428 
crossed for at least ten generations onto a C57BL/6J background. Animals were housed under 429 
specific pathogen-free conditions under standard housing conditions of 12h light cycle, 21°C and 430 
relative humidity of 55-65. Male WT and CD169 KO mice were used at 9-10 weeks for the 431 
confirmatory experiment and of 20 weeks for the pilot experiment. 432 
 433 
Infection experiments 434 
A total of 132 CD1 mice were used in this study. Sample size calculations were based on long 435 
standing experience with the infection models used57-59. Mice were randomised to cages and 436 
were challenged intravenously (i.v.) as previously described57-59 with 1.1x105or 1x106 437 
CFU/mouse. At pre-set time points, pre-selected groups were sacrificed for the collection of blood 438 
and organ samples. Bacteria were enumerated by plating on selective medium. The bacterial 439 
doses for the experiments described herein were selected based on previous experience, in 440 
order to raise bacteraemia in at least 50% of the mice.  441 
Experiments in C57BL/6J WT and CD169 KO mice included a confirmatory experiment using 442 
n=6/group and a pilot experiment of n=3/group. Mice were infected with 2 x 106 CFU/mouse with 443 
S. pneumoniae D39 via intravenous injection.  Mice were monitored over a 6h period with no 444 
clinical signs observed. 6h post infection, mice were sacrificed by exposure to a rising 445 
concentration of carbon dioxide and blood taken by cardiac puncture. Whole blood was frozen in 446 
1 ml RPMI/15% glycerol. Spleen was removed and half stored in 1 ml RPMI/15% glycerol. The 447 
remaining half was embedded and frozen in OCT. All samples were processed in Leicester. 448 
The operator carrying out the sample and data analysis was blined for all experiemnts regarding 449 
the C57BL/6J mice, but not for work on CD1 mice. 450 
 451 
 452 
CD169 blockade 453 
Blockade experiments were performed by intravenously injecting 10 µg of anti-CD169 mAb (Rat 454 
IgG2a,k, Clone: 3D6.112), or isotype matched control (Rat IgG2a, clone RTK2758) 30 minutes 455 
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prior to intravenous infection with 106 CFU S. pneumoniae D39 through the lateral tail vein. The 456 
distribution of the anti-CD169 mAb was assessed in the spleen through microscopy of sections 457 
(Supplementary Figure 5 b). Blood was taken by tail bleed, 24 hours after infection, to enumerate 458 
the number of CFU in the blood. Mice were culled at 72 hours post-infection, or when they 459 
showed moderate signs of disease in accordance with the home office licence. Blood were taken 460 
by cardiac puncture at death, and spleens were either frozen in OCT, or homogenised, serially 461 
diluted and plated to count viable bacteria. In all cases, death was confirmed by cervical 462 
dislocation. Signs of disease were monitored throughout the course of the experiments. Two 463 
independent receptor blockade experiments were performed, each with two groups of 5 mice (20 464 
mice total). 465 
 466 
Confocal Microscopy 467 
Confocal imaging was performed on infected spleen sections and uninfected controls. The 468 
organs were frozen in dry ice, in Optimum Cutting Temperature (OCT) embedding matrix 469 
(Thermoscientific). A Leica CM1850UV cryostat was used to slice the tissues; 8 µm thick sections 470 
were cut and mounted on gelatin coated microscopy slides. Organ sections were then dried for 471 
10 min at room temperature (RT) before fixing in phosphate-buffered saline (PBS) containing 4% 472 
v/v EM grade formaldehyde (Sigma) for 20 min at RT. Samples were washed three times in PBS, 473 
and incubated for 10 min with PBS containing 0.1% v/v Triton-x100 to permeabilise the tissues. 474 
Samples were then incubated for 30 min in blocking solution (PBS containing 5% v/v goat 475 
serum). Sections were incubated for 1 h with primary antibodies diluted in blocking solution, 476 
washed three times with PBS, and then incubated for 45 min with secondary antibody solution. 477 
Samples were then washed three times with PBS and once with H2O before adding the mounting 478 
medium containing DAPI (Thermoscientific ProLong Gold Antifade Mountant) and closing the 479 
slides with coverslips. Anti-serotype 2 and 4 capsule antibodies (Statens Serum Institute) were 480 
used to stain non-fluorescent bacteria. Different macrophages populations were labelled using a 481 
panel of antibodies (Supplementary Table 1). Metallophilic macrophages were labelled by anti-482 
Mouse CD169 and the recombinant protein CR-Fc, which binds mannose receptor ligands 483 
expressed by the metallophilic CD169-positive macrophages61. Marginal zone macrophages 484 
were labelled with, anti-Mouse CD209b (SIGN-R1, eBioscience) and anti-Mouse F4/80 antibody 485 
(eBioscience). For other classes of immune cells, the following antibodies were used: anti-CD3 486 
(clone Kt3 specific for T cells), anti-B220 (specific for B cells) and anti-FDC-M1 mAb (4C11 487 
specific for follicular dendritic cells). For the studies of bacterial localisation Alexafluor 633-488 
conjugated Wheat germ agglutinin and Alexafluor 647-conjugated phalloidin (Actin; 489 
Thermoscientific) were used. The porcine spleen samples were stained with anti-porcine CD169  490 
and anti-porcine CD163 (both Biorad) (Supplementary Table 1). Combinations of Alexafluor 491 
conjugated antibodies from Thermoscientific were used as secondary antibodies (488, 568 or 647 492 
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with different host specificity) (Supplementary Table 1). An Olympus FV1000 confocal laser 493 
scanning microscope was used to acquire the images using 20X and60X objectives, and the free 494 
software ImageJ (http://imagej.nih.gov/ij/) was used for image processing. For visualization 495 
purpose some images were deconvolved using Huygens Essential deconvolution software 496 
version 16 (Scientific Volume Imaging,  Netherlands) and viewed in Imaris 3D reconstruction 497 
software 9.4  (Bitplane, Switzerland). 498 
 499 
Scanning of microscopy sections and spleen area measurements 500 
Spleen sections were stained with different combinations of antibodies in order to identify the 501 
different spleen compartments. The sections were scanned using a fully motorised Nikon Eclipse 502 
Ti microscope equipped with a Plan Fluor 10X/0.3 objective and an Andor iXonEM+ EMCCD DU 503 
885 camera. Automatic tissue scanning was performed using NIS-Elements software AR 504 
4.51 (Nikon, Japan) and the images obtained were analysed using ImageJ software 1.51. Using 505 
the DAPI signal, the total area of each tissue section was calculated. Four different spleen 506 
compartments were identified and their areas calculated: white pulp, metallophilic macrophages, 507 
marginal zone and red pulp macrophages. The white pulp areas were defined as those areas that 508 
stained with a combination of B220 (B cells), CD3 (T cells) enclosed within the metallophilic rings 509 
stained withSiglec-1 (metallophilic macrophages marker). The areas of metallophilic 510 
macrophages (Siglec-1), marginal zone macrophages (SIGN-R1) and red pulp macrophages 511 
(F4/80) were defined as those areas stained for each cell marker. The proportion of the spleen 512 
compartments with respect to the total was calculated using the data obtained from at least 5 513 
different images for each staining combination (Supplementary Figure 3). For neutrophils 514 
quantification cells were detected with an Ly-6G specific primary antibodies, and numbers of 515 
neutrophils were enumerated in at least 5 fields from 3 independent, biological replicates. 516 
 517 
Transmission Electron Microscopy 518 
Excised tissue was primarily fixed with 4% v/v Formaldehyde / 0.5% Glutaraldehyde in sodium 519 
cacodylate buffer with 2uM of calcium chloride overnight, followed by several washes in same 520 
buffer. The samples were post-fixed with aqueous 1% w/v osmium tetroxide/ 1.5% w/v potassium 521 
ferrocyanide for 60 min, washed with distilled, de-ionised water, followed by a further 60 minutes 522 
in 1% w/v aqueous osmium. After further washes with DDW, the tissue was en bloc stained in 2% 523 
w/v aqueous uranyl acetate for 60 min.  Following dehydration through an ethanol series, the 524 
samples were treated with several short washes through ice cold acetone, before gradual 525 
infiltration with Durcopan resin (Sigma-Aldrich UK). Once fully infiltrated with Durcupan, the tissue 526 
was embedded in BEEM capsules, and polymerised at 60oC for 48 h. 527 
Thin sections, of approximately 80 nm thickness, were cut from each sample using a Leica UC7 528 
ultramicrotome, collected on copper mesh grids and counter stained Reynolds’ lead citrate. 529 
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Sections were observed using a JEOL JEM-1400 transmission electron microscope, using an 530 
accelerating voltage of 100 kV.  Digital Images were recorded using a SIS Megaview III Digital 531 
Camera  (Olympus Soft Imaging Solutions, Germany) with iTEM Software V 5.1 (Olympus, 532 
Germany). 533 
 534 
Porcine spleen perfusion model of infection 535 
The methodology for perfusion of the porcine spleen was similar to that described previously for 536 
the perfusion of liver and kidney 32. Porcine spleens were collected from a local abattoir from 537 
domestic Large White pigs (40–50kg) immediately after slaughter. Following a midline 538 
laparotomy, a splenectomy was carried out close to its hilum. To perfuse the organ, the celiac 539 
trunk was isolated and cannulated, while the other arteries were carefully ligated and divided. The 540 
spleen was then perfused with saline solution containing heparin (LEO Laboratories Limited, UK) 541 
and human urokinase (Syner-Medica Ltd, UK) through the main splenic artery, and the blood 542 
excess was flushed out through the main splenic vein. The perfusion set-up consists of a SARNS 543 
8000 extracorporeal roller pump (3M, St. Paul, MN, USA), Baby-RX venous reservoir and 544 
membrane oxygenator (Terumo, Ann Arbor, MI, USA), metal organ chamber, PVC tubings 545 
(Cellplex, Dandenong, VIC, Australia) and water bath temperature regulator. 546 
The perfusate consisted of 1 litre of autologous whole blood collected via exsanguination, 547 
containing the two antimicrobials nalidixic acid (10 mg/L) and colistin (5 mg/L), glucose (5 ml/h), 548 
500 µg epoprostenol sodium (vasodilatation), and 5000 IU heparin (microclots prevention; 549 
1500units/hr). The temperature of the water bath was set at 39°C and oxygenation at 2 L/min. 550 
When the blood was warm and oxygenated, the organ was connected to the system. Initial flow 551 
rate was set at 0.2 L/min, adjusted to maintain a mean arterial pressure (MAP) at 70–80 mm Hg.  552 
As soon as the perfused spleen reached a stable flow (typically 30 min), the arterial circuit was 553 
injected with S. pneumoniae. Over the subsequent 5 h, serial blood samples and spleen biopsies 554 
were taken. Blood gas analysis was performed before and after the infection at predetermined 555 
time points to verify the functionality of the organ. Overall four infection perfusion experiments, 556 
and three negative controls using non-infected perfused organs were performed. 557 
 558 
Statistical analysis 559 
GraphPad Prism software version 6 was used to analyse all data. Fisher’s exact test was used to 560 
compare different cohorts of mice with the assumption that all samples containing more than 100 561 
CFU/ml (or CFU/mg) were positive and the others negative. One-way Anova, with Tukey’s post-562 
test, was used to compare the distribution of foci of bacteria in the spleen. Survival curves have 563 
been compared with a Log-rank (Mantel-Cox) test. Results were considered significant when P 564 
values were <0.05. Error bars in all figures show the Standard Deviation, unless otherwise stated.  565 
 566 
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Data availability  567 
The data that support the findings of this study are available from the corresponding author upon 568 
request. The recombinant protein CR-Fc, which binds mannose receptor ligands expressed by 569 
the metallophilic CD169-positive macrophages can be obtained for Luisa Martinez-Pomares and 570 
the CD169 knock out mice and their isogenic C57/BL6 controls can be obtained from Paul 571 
Crocker. 572 
  573 
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 799 
Figure 1: The eclipse phase of pneumococcal bacteraemia. CD1 mice (n=15) were 800 
infected intravenously with 1x106 pneumococci (strain D39). (a) Shows the numbers of 801 
bacteria in the blood at 6h, 8h and 24h (filled circles, positive blood cultures; empty circles, 802 
negative blood cultures). In the spleen (b), bacteria can be found both at 6h and at 8 h after 803 
inoculation. Values are expressed as CFU/ml in blood or CFU/g of spleen [weight 100 to 200 804 
mg]. The limit of detection is shown as a dotted line. Statistical differences (* P < 0.05, 805 
Fisher’s exact test, one tailed) are indicated by thin black lines. Panels c to e show 806 
representative immunofluorescence microscopy images of on infected spleen sections. 807 
Single optical sections (analysis of 5 sections from 3 different spleens for each staining 808 
combination) obtained from 6 h infected spleens show the presence of bacterial clusters as 809 
small green dots (c, 20x objective and d, 60x objective) which can be seen as clusters of 810 
single bacteria at a higher magnification (e, 60x objective). In panel c bacteria are shown in 811 
green (α-type2, AF488), bacterial foci are indicated by green circles, metallophilic 812 
macrophages in red (Cr-Fc, AF568b) and red pulp macrophages in magenta (α-F4/80, 813 
AF647). In panel d, bacterial clusters (green circles, α-type2, AF568) can be observed in the 814 
metallophilic macrophages area (Cr-Fc, AF647), in white marginal zone macrophages are 815 
also stained (aSIGN-R1b, AF488s). In panel e a big cluster of bacteria is shown in green (α-816 
type2, AF488), nuclei in blue (DAPI) and actin in orange (pAF647 conjugated phalloidin). 817 
Antibody details in Supplementary Table 1.  818 
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 819 
Figure 2: Numbers of pneumococci within clusters, founded by single cells, increase 820 
over time in the infected spleens. (a-d) Immunofluorescence microscopy (representative 821 
of 5 sections from 3 different samples) on spleen sections of CD1 mice infected by S. 822 
pneumoniae D39 shows an increase of the number of bacteria in the foci of infection over 823 
time: (a) 5m; (b) 4h; (c) 6h and (d) 8 h. Splenic architecture was identified by staining the red 824 
pulp magenta (α-F4/80, AF647), the metallophilic ring areas in red (Cr-Fc, AF568b) and 825 
nuclei in blue (DAPI). Bacteria (green, α-type2, AF488) are trapped in the marginal sinus 826 
already at 30 minutes (a) and after an initial clearance, the number and size of the foci 827 
increased (b-c-d). A deeper analysis of those images futher confirmed the increase of 828 
bacteria in time (e); for each time point, 25 microscope fields (60X magnification) were 829 
analysed to count the number of bacteria per focus (open circles) and number of foci. The 830 
trend line represents the arithmetic mean number of bacteria per focus, error bars show SD, 831 
statistical significance was determined using an ordinary one-way ANOVA with multiple 832 
comparisons. * P<0.05, **** p<0.0001. A representative spleen section of mice infected with 833 
GFP-D39 and RFP-D39 (n=4) labelled bacteria show how the pneumococci are present in 834 
clusters each of which is comprises either exclusively green or exclusively red fluorescent 835 
bacteria (green or red circles). Bacterial counts are shown in Supplementary Table 2. I In 836 
white metallophilic macrophages are also shown (Cr-Fc, AF568b) (f). In a representative 837 
spleen section 8 h after infection the neutrophil granulocytes in magenta (α-GR1, AF647) are 838 
seen in the red pulp (g) and do not colocalise with marginal zone macrophages (Cr-Fc, 839 
AF568b). At a higher magnification (60x, panels h-j), the neutrophils were found to localise 840 
next to all foci of infection in the red pulp (RP, α-F4/80, AF647) (h), but not in the marginal 841 
25 
 
zone (MZM, nearby metallophilic macrophages are stained red, Cr-Fc, AF568b) (i) and in the 842 
metallophilic area (MMM, red, Cr-Fc, AF568b) (j). Five spleen sections from three mice each 843 
were analysed for this study, allowing for quantification of the number of neutrophils per 844 
square μm within the red pulp (k) and to quantify the number of neutrophils within a 25 μm 845 
radius of 5 or more discreet infectious foci in each zone of the spleen (l) (black bar 6h; grey 846 
bar 8 h). Error bars show SD, statistical significance was determined using a two tailed one-847 
way ANOVA with Tukey’s post correction, * p<0.05, *** P<0.001, **** p<0.0001. Antibody 848 
details are in Supplementary Table 1.  849 
  850 
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 851 
Figure 3: Tissue localisation of infectious foci in the spleen. Panel a shows the 852 
distribution of the foci of pneumococci at 6 h after infection normalized for the area of each 853 
spleen compartment (Supplementary Figure 4). Compartment analysed were the white pulp 854 
(WP), the metallophilic macrophage area (MMM), the marginal zone macrophage area 855 
(MZM) and the red pulp area (RP) of the spleen. Three infected mice groups have been 856 
considered for this analysis: mice infected with high dose (1 x 106 CFU) of S. pneumoniae 857 
(black bars), mice infected with low dose (1 x 105 CFU) (grey bars) and mice infected with 858 
1x106 CFU of the D39 after blocking with CD169 mAb (white bars). Counts were obtained 859 
from 30 random microscope fields from three independent infected spleens. Error bars show 860 
SD, Statistical differences in the percentages between the different infected groups are 861 
reported **** P< 0.0001 (two-tailed one-way ANOVA). Number of bacteria per focus for the 862 
each spleen compartment are shown in panel b. Mean (lines) and SD (error bars) are 863 
reported.  Panels c to e report data on mouse infections with the nanA mutants (n=22). 864 
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Panel c shows the survival graph (black wt n=5, blue ΔnanA n=5, *** P<0.001, kaplan-meier 865 
two-tailed test)  and panel d the distribution of foci of infection in the metallophilic 866 
macrophages in mice infected with bacteria expressing wt NanA, no NanA (ΔnanA), 867 
NanAΔ290-786 (sialidase domain deletion), and NanAΔ76-282 (lectin domain deletion). 868 
Three independent spleens from mice infected with each nanA mutant were analysed to 869 
determine the localisation of foci. 20 fields were analysed from each spleen with a 40x 870 
objective. The data show the mean and standard deviation of 3 biological replicas. Statistical 871 
significance were determined using an ordinary one-way ANOVA with multiple comparisons, 872 
*** p<0.001, **** p<0.0001. Spleen section of D39ΔnanA infected mice (panel e, 873 
representative of 5 sections from 3 different samples) show bacterial foci (green circles) 874 
localising exclusively to the marginal zone (not stained) or the red pulp. Red pulp 875 
macrophages are shown in in magenta (α-F4/80, AF647), metallophilic macrophages in red 876 
(Cr-Fc, AF568b) an bacteria in green (α-type2, AF488). Panels from f to h show the data 877 
about blocking the CD169 receptor on metallophilic macrophages with a specific mAb (Rat 878 
IgG2a,k, Clone: 3D6.112) prior to infection. Panel f shows that in a representative spleen 879 
section (5 sections from 3 different samples), 4 hours after infection, bacterial clusters (green 880 
circles) do not localise anymore to the metallophilic macrophages (red) while they still are 881 
present in the marginal zone (white) or in the red pulp (black). Antibody details in 882 
Supplementary Table 1. Panel g shows the levels of bacteraemia 24 hours post-infection 883 
indicated by the number of CFU/mL of blood in mice treated with either anti-CD169 blocking 884 
antibody or with the isotype matched control (left, Isotype control, n=10, right, CD169 mAb, 885 
n=10). The dotted line indicates the limit of detection. Statistical significance were tested 886 
using a Mann-Whitney test. *** p=<0.001. In panel h the survival graph of the same 887 
experiment is reported (black, Isotype control, n=10, red, CD169 mAb, n=10, *** P<0.001, 888 
kaplan-meier two-tailed test) .  889 
  890 
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 891 
Figure 4: The intracellular phase of S. pneumoniae in the early stages before overt 892 
septicaemia. Panel a-c show three orthogonal views of intracellular pneumococci (green 893 
gfp), in this representative (5 sections from 3 different samples) multi-stack acquisition the 894 
green GFP-tagged bacteria are localised within the cytoplasm of the host cells 4 hours after 895 
the infection (60X magnification). The plasma membrane is shown in red (WGA 633 896 
conjugated) and nuclei are stained in blue (DAPI). Three-dimensional reconstruction through 897 
deconvolution analysis clarifies the localisation of the pneumococci within the host cell (d-e). 898 
Further analysis with transmission electron microscopy identified groups of pneumococci in 899 
the cytoplasm of splenic macrophages. A representative image at 6000X magnification is 900 
shown in panel f (3 spleens analysed), while panel g is showing an enlarged insert of the 901 
same image (20000X magnification). The importance of the pneumococcal intracellular 902 
phase was assessed by treating CD1 mice after the infection (dose of 1 x 106 CFU of strain 903 
D39) with antibiotics that have different penetration rates into the host cells (h-j). Two doses 904 
of both erythromycin (high penetration rate) and ampicillin (low penetration rate) were 905 
administered intraperitoneally at 1 and 5 h post-infection to groups of mice (12-13 animal per 906 
group). The doses were chosen so that the predicted drug half-life would reduce the drug 907 
plasma levels in 11 h to the minimal inhibitory concentration (MIC). Blood counts at 24 h 908 
after infection (panel h) show antibiotics to be equally effective in preventing bacteraemia in 909 
comparison to control (p<0.001). The limit of detection is shown as a dotted line. Analysis of 910 
later time points indicate that survival is greater significantly higher in the erythromycin group 911 
(blue) both with respect to the ampicillin group (red) and control (panel i). **** P<0.0001 912 
kaplan-meier two-tailed test. Survival correlates to the terminal bacterial blood and spleen 913 
counts which are lower in erythromycin (ery) treated mice with respect to control in blood 914 
and to both control and ampicillin (amp) in the spleen (panel j). (**** P<0.0001, * P<0.05, 915 
Fisher’s exact test, one tailed) 916 
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 918 
Figure 5: The pig spleen perfusion as a model of infection with S. pneumoniae. 919 
Pneumococci grow in vitro with a doubling time of approximately 45 min in heparinised 920 
porcine blood (a). In the ex vivo spleen perfusion model D39 pneumococci injected into the 921 
arterial circuit are taken up by the spleen and cleared from the blood over time (b). The data 922 
show the average number of CFU recovered from blood samples (red) and spleen biopsies 923 
(black) of three independent experiments. Error bars represent standard deviation. 924 
Immunofluorescence microscopy of infected spleen sections showed an increase of the size 925 
of the foci of infection over time (c-e). Bacteria were stained in green (α-type2, AF488), 926 
CD169+ macrophages in red (α-CD169p, AF568c) and nuclei in blue (DAPI). Actin staining 927 
(in magenta) was used to identify the endothelial tissue of the arterioles (pAF647 conjugated 928 
phalloidin). In five-hour infected spleen sections GFP-D39 (green) and RFP-D39 (red) 929 
labelled bacteria are present in foci of infection (circles) containing either exclusively green 930 
or exclusively red fluorescent bacteria respectively (f-h) (actin in magenta and nuclei in blue). 931 
Sections of five hours infected porcine spleens are shown in panels i and j. Clusters of 932 
pneumococci were found localised in the CD169+ macrophages of porcine spleens in the 933 
perifollicular sheath (i-j). Inserts to the left in both panel i and j show the microarchitecture 934 
evidenced by actin staining (magenta) and the distribution of CD169+ macrophages (α-935 
CD169p, AF568c), while the enlarged view is an enlarged view of the focus detected in the 936 
left upper panels. Staining was done as for Fig 5c. All the immunofluorescence images are 937 
representative of 5 sections from 3 different samples. Antibody details are in Supplementary 938 
Table 1. 939 
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